A detailed history of Hbw Advisory Services LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hbw Advisory Services LLC holds 10,284 shares of PFE stock, worth $305,023. This represents 0.05% of its overall portfolio holdings.

Number of Shares
10,284
Previous 7,391 39.14%
Holding current value
$305,023
Previous $205,000 40.0%
% of portfolio
0.05%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$25.26 - $29.6 $73,077 - $85,632
2,893 Added 39.14%
10,284 $287,000
Q4 2023

Jan 16, 2024

SELL
$26.13 - $33.94 $221,530 - $287,743
-8,478 Reduced 53.42%
7,391 $213,000
Q3 2023

Oct 11, 2023

SELL
$32.09 - $37.51 $17,071 - $19,955
-532 Reduced 3.24%
15,869 $526,000
Q2 2023

Jul 05, 2023

BUY
$36.12 - $41.79 $64,835 - $75,013
1,795 Added 12.29%
16,401 $602,000
Q1 2023

Apr 07, 2023

SELL
$39.39 - $51.28 $25,288 - $32,921
-642 Reduced 4.21%
14,606 $596,000
Q3 2022

Oct 05, 2022

BUY
$43.76 - $53.42 $168,519 - $205,720
3,851 Added 33.79%
15,248 $668,000
Q2 2022

Jul 13, 2022

SELL
$46.53 - $55.17 $93,851 - $111,277
-2,017 Reduced 15.04%
11,397 $598,000
Q1 2022

Apr 18, 2022

SELL
$45.75 - $56.69 $261,003 - $323,416
-5,705 Reduced 29.84%
13,414 $694,000
Q4 2021

Jan 11, 2022

BUY
$41.32 - $61.25 $26,444 - $39,200
640 Added 3.46%
19,119 $1.13 Million
Q3 2021

Oct 08, 2021

BUY
$39.25 - $50.42 $73,750 - $94,739
1,879 Added 11.32%
18,479 $794,000
Q2 2021

Jul 15, 2021

BUY
$35.91 - $40.68 $212,515 - $240,744
5,918 Added 55.4%
16,600 $650,000
Q1 2021

Apr 13, 2021

BUY
$33.49 - $37.77 $134,964 - $152,213
4,030 Added 60.58%
10,682 $387,000
Q4 2020

Jan 12, 2021

BUY
$33.47 - $42.56 $19,680 - $25,025
588 Added 9.7%
6,652 $245,000
Q3 2020

Oct 14, 2020

BUY
$31.75 - $37.25 $192,532 - $225,884
6,064 New
6,064 $223,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hbw Advisory Services LLC Portfolio

Follow Hbw Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbw Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbw Advisory Services LLC with notifications on news.